Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 17
2014 8
2015 4
2016 4
2017 8
2018 25
2019 17
2020 14
2021 26
2022 28
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab in enteropathic arthritis.
Ulusoy BÖ, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Ulusoy BÖ, et al. Among authors: erden a. Immunotherapy. 2023 Jun;15(8):583-592. doi: 10.2217/imt-2022-0197. Epub 2023 Apr 5. Immunotherapy. 2023. PMID: 37020400
Tofacitinib experience in patients with enteropathic arthritis.
Dağlı PA, Erden A, Güven SC, Armağan B, Yürekli ÖT, Özin YÖ, Omma A, Küçükşahin O. Dağlı PA, et al. Among authors: erden a. Immunotherapy. 2023 Jun;15(8):619-626. doi: 10.2217/imt-2022-0110. Epub 2023 Apr 3. Immunotherapy. 2023. PMID: 37009645 Review.
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study.
Yagiz B, Lermi N, Coskun BN, Dalkilic E, Kiraz S, Erden A, Ertenli I, Duran E, Bilgin E, Yılmaz R, Ateş A, Tufan A, Küçük H, Mercan R, Cinaklı H, Akar S, Yaşar Bilge NŞ, Kaşifoglu T, Türk SM, Gonullu EO, Bes C, Alpay Kanitez N, Emmungil H, Kalyoncu U, Pehlivan Y. Yagiz B, et al. Among authors: erden a. Rheumatology (Oxford). 2023 Dec 1;62(12):3962-3967. doi: 10.1093/rheumatology/kead318. Rheumatology (Oxford). 2023. PMID: 37354493
Some concerns and improvements from Turkey.
Cinar OE, Erden A, Sari A, Armagan B, Kilic L. Cinar OE, et al. Among authors: erden a. Ann Rheum Dis. 2018 Jun;77(6):e28. doi: 10.1136/annrheumdis-2017-211963. Epub 2017 Aug 10. Ann Rheum Dis. 2018. PMID: 28798052 No abstract available.
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
Kalyoncu U, Bilgin E, Erden A, Satış H, Tufan A, Tekgöz E, Ateş A, Coşkun BN, Yağız B, Küçükşahin O, Yazısız V, Kimyon G, Bes C, Başıbüyük CS, Alkan S, Cesur TY, Ertenli İ, Kiraz S. Kalyoncu U, et al. Among authors: erden a. Clin Exp Rheumatol. 2022 Nov;40(11):2071-2077. doi: 10.55563/clinexprheumatol/9h6dtb. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35084323 Free article.
Pulmonary hypertension in Takayasu arteritis.
Sari A, Sener YZ, Firat E, Armagan B, Erden A, Oksul M, Hekimsoy V, Asil S, Kilic L, Kiraz S, Kaya EB, Tokgozoglu L, Akdogan A. Sari A, et al. Among authors: erden a. Int J Rheum Dis. 2018 Aug;21(8):1634-1639. doi: 10.1111/1756-185X.13354. Int J Rheum Dis. 2018. PMID: 30146739
Reducing length of hospital stay with colchicine.
Karakaş Ö, Erden A, Güven SC, Armağan B, Sahiner ES, Kurtipek AC, Inan O, Gemcioglu E, Ateş İ, Omma A, Küçüksahin O. Karakaş Ö, et al. Among authors: erden a. J Infect Dev Ctries. 2022 Jan 31;16(1):57-62. doi: 10.3855/jidc.14924. J Infect Dev Ctries. 2022. PMID: 35192522 Free article.
158 results